NCT00420381 2020-12-19Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal CancerEli Lilly and CompanyPhase 2 Completed28 enrolled 13 charts
NCT00391118 2020-10-19Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")Eli Lilly and CompanyPhase 2 Completed153 enrolled 20 charts